GMAPX
Price
$35.32
Change
-$0.14 (-0.39%)
Updated
Jul 31 closing price
Net Assets
1.01B
NAESX
Price
$141.37
Change
-$0.34 (-0.24%)
Updated
Jul 31 closing price
Net Assets
188.57B
Interact to see
Advertisement

GMAPX vs NAESX

GMAPX vs NAESX Comparison Chart in %
View a ticker or compare two or three
VS
GMAPX vs. NAESX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GMAPX is a Hold and NAESX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
NAESX has more cash in the bank: 189B vs. GMAPX (1.01B). NAESX pays higher dividends than GMAPX: NAESX (1.10) vs GMAPX (0.56). GMAPX was incepted earlier than NAESX: GMAPX (8 years) vs NAESX (66 years). GMAPX (0.92) is less costly to investors than NAESX (0.17). GMAPX is a more actively managed with annual turnover of: 162.00 vs. NAESX (17.00). GMAPX (0) and NAESX (0) have matching initial minimum investment requirements. GMAPX annual gain was more profitable for investors over the last year : 27.88 vs. NAESX (22.56). NAESX return over 5 years is better than : 34.95 vs. GMAPX (4.48).
GMAPXNAESXGMAPX / NAESX
Total Expense Ratio0.840.17494%
Annual Report Gross Expense Ratio0.920.17541%
Fund Existence8 years66 years-
Gain YTD21.25014.563146%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets1.01B189B1%
Annual Yield % from dividends0.561.1051%
Returns for 1 year27.8822.56124%
Returns for 3 years41.3343.3095%
Returns for 5 years4.4834.9513%
Returns for 10 yearsN/A155.28-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VMMSX32.150.39
+1.23%
Vanguard Emerg Mkts Sel Stk Inv
VRGWX936.977.54
+0.81%
Vanguard Russell 1000 Growth Index I
GIDWX20.040.13
+0.65%
Goldman Sachs US Eq Div and Premium R6
CAVAX18.710.04
+0.21%
SEI Catholic Values Equity F (SCVT)
RYOIX86.56-2.00
-2.26%
Rydex Biotechnology Inv